During the plant construction boom in the late 2000s due to high crude oil prices, they adopted a selective order strategy, reducing sales while achieving record-high profits.

[12] While the scale of their business in this sector isn't massive, they also have a track record in the life sciences field related to medical and pharmaceuticals.

Moreover, they are earnestly embarking on environmental businesses, including carbon credit trading, and participation in water quality improvement projects in China has been reported.

In North America, they have started an oil development business as a 100% owned operator (producing about 1,000 barrels per day), indicating a notable expansion beyond plants.

[12] Every month, on the last day, they advertise prominently on the front page of the morning edition of the Nihon Keizai Shimbun newspaper.